Skip to content

Search

Showing results for "A"

The Kids Research Institute Australia researchers share in State Government science grants

Four The Kids Research Institute Australia researchers are among those who have received funding in the WA State Government's Merit Award Program announced today.

An evening for the future of autism

Join Dr Andrew Whitehouse, head of Developmental Disorders research at The Kids, as he shares with you his vision for autism research.

Aboriginal Health Researchers Win Major Discovery Grants

esearchers from Perth's Centre for Research Excellence in Aboriginal Health and Wellbeing have won more than $1.3 million in competitive funding

Aboriginal researcher NAIDOC Person of the Year

The head of Indigenous research at Perth's The Kids for Child Health Research has been honoured as the 2008 National NAIDOC Person of the Year.

Innovative Playful Learning Approaches to Improve Children’s Readiness for Primary Education in Uzbekistan

The Government of Uzbekistan has committed to reforming preschool education, prioritising upskilling teachers to use international best practice.

Why get active?

Anyone who engages in physical activity, regardless of how much they do, can achieve mental, physical and social health benefits, resulting in benefits to their quality of life.

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

Nirsevimab is an extended half-life monoclonal antibody to the respiratory syncytial virus (RSV) fusion protein that has been developed to protect infants for an entire RSV season. Previous studies have shown that the nirsevimab binding site is highly conserved. However, investigations of the geotemporal evolution of potential escape variants in recent (ie, 2015–2021) RSV seasons have been minimal.

Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018

Multiple studies have shown an association between intussusception (IS) and receipt of monovalent or pentavalent rotavirus vaccine (RV) in the previous 21 days. Disease severity is an important consideration for risk-benefit evaluations of RV, but no studies have compared the severity of IS within 21 days of vaccination (vaccine-associated, VA) and later (not temporally-associated, VNA).